User profiles for Dipanwita Mitra

Dipanwita Mitra

National Cancer Institute
Verified email at nih.gov
Cited by 604

Effective inhibition of SARS-CoV-2 entry by heparin and enoxaparin derivatives

…, F Zhang, VH Pomin, NM Ashpole, D Mitra… - Journal of …, 2021 - Am Soc Microbiol
Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has caused a
pandemic of historic proportions and continues to spread globally, with enormous consequences …

[HTML][HTML] The rapid diagnosis and effective inhibition of coronavirus using spike antibody attached gold nanoparticles

A Pramanik, Y Gao, S Patibandla, D Mitra… - Nanoscale …, 2021 - pubs.rsc.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the coronavirus
disease that began in 2019 (COVID-19), has been responsible for 1.4 million deaths …

Aptamer conjugated gold nanostar-based distance-dependent nanoparticle surface energy transfer spectroscopy for ultrasensitive detection and inactivation of corona …

A Pramanik, Y Gao, S Patibandla, D Mitra… - The journal of …, 2021 - ACS Publications
The ongoing outbreak of the coronavirus infection has killed more than 2 million people.
Herein, we demonstrate that Rhodamine 6G (Rh-6G) dye conjugated DNA aptamer-attached …

The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica

W Jin, W Zhang, D Mitra, MG McCandless… - International journal of …, 2020 - Elsevier
The SARS-CoV-2 spike glycoproteins (SGPs) and human angiotensin converting enzyme 2
(ACE2) are the two key targets for the prevention and treatment of COVID-19. Host cell …

[HTML][HTML] Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein

R Tandon, D Mitra, P Sharma, MG McCandless… - Scientific reports, 2020 - nature.com
Pseuodotyped particles have significant importance and use in virology as tools for studying
the biology of highly pathogenic viruses in a lower biosafety environment. The biological, …

[HTML][HTML] The degree of polymerization and sulfation patterns in heparan sulfate are critical determinants of cytomegalovirus entry into host cells

D Mitra, MH Hasan, JT Bates, MA Bierdeman… - PLoS …, 2021 - journals.plos.org
Several enveloped viruses, including herpesviruses attach to host cells by initially interacting
with cell surface heparan sulfate (HS) proteoglycans followed by specific coreceptor …

Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virus

…, R Tandon, JT Bates, DR Ederer, D Mitra… - Carbohydrate …, 2021 - Elsevier
Severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) has resulted in a
pandemic and continues to spread at an unprecedented rate around the world. Although a …

Enhanced interfacial evaporation and desalination by solar heat localisation using nitrogenated graphitic carbon and Co3O4 nanorods

D Mitra, K Chanda, S Bhattacharjee, P Bairi… - Solar Energy Materials …, 2023 - Elsevier
The problem of worldwide scarcity of clean water can be resolved efficiently by utilizing the
significant heat localizing capability of the solar-driven interfacial evaporator with a nominal …

[HTML][HTML] Incidence of postoperative nausea and vomiting following gynecological laparoscopy: A comparison of standard anesthetic technique and propofol infusion

…, A Gupta, KS Kapoor, RK Jain, T Nag, D Mitra… - Acta Anaesthesiologica …, 2016 - Elsevier
Objective To determine the safety, efficacy, and feasibility of propofol-based anesthesia in
gynecological laparoscopies in reducing incidences of postoperative nausea and vomiting …

Design, Synthesis, and Preliminary Studies of Spiro-isoxazoline-peroxides against Human Cytomegalovirus and Glioblastoma∥

P Das, MH Hasan, D Mitra, R Bollavarapu… - The Journal of …, 2019 - ACS Publications
The association between glioblastoma (GBM) and human cytomegalovirus (HCMV) infection
has been the intensely debated topic over the decades for developing new therapeutic …